Submitted by GAtherton on 7 July 2015
Recently launched.
RDI is a EURORDIS initiative, created in partnership with national alliances. The preliminary phase of the initiative is steered by EURORDIS and national rare disease alliances from the US (NORD), Canada (CORD), Japan (JPA), China (CORD), India (I-ORD), the Ibero-American pan-regional alliance (ALIBER) and the International Federation for Epidermolysis Bullosa (DEBRA International).
The main objectives of RDI are:
“-To promote rare diseases as an international public health and research priority by raising public awareness and influencing policy-making;
-To represent members and people living with a rare disease in international institutions such as the World Health Organisation and the United Nations Economic and Social Council; and
-To enhance the capacities of members to improve the lives of those living with or affected by a rare disease through information exchange, networking, mutual support and joint actions.”
Along with advocating for rare diseases in international forums and multilateral institutions, they will also coordinate and participate in the International Rare Disease Research Consortium (IRDiRC). RDI will enhance partnerships and liase closely with Orphanet, International Alliance of Patients’ Organizations (IAPO), International Conference on Rare Diseases & Orphan Drugs (ICORD), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), International Federation of Human Genetics Societies (IFHGS).
“RDI creates a united global patient voice for all people living with a rare disease around the world, including those who don’t have a voice today, and works to turn ignorance, isolation and exclusion into knowledge, solidarity and hope,” says Yann Le Cam, Chief Executive Officer of EURORDIS, the European Organisation for Rare Diseases.
For further information
The main objectives of RDI are:
“-To promote rare diseases as an international public health and research priority by raising public awareness and influencing policy-making;
-To represent members and people living with a rare disease in international institutions such as the World Health Organisation and the United Nations Economic and Social Council; and
-To enhance the capacities of members to improve the lives of those living with or affected by a rare disease through information exchange, networking, mutual support and joint actions.”
Along with advocating for rare diseases in international forums and multilateral institutions, they will also coordinate and participate in the International Rare Disease Research Consortium (IRDiRC). RDI will enhance partnerships and liase closely with Orphanet, International Alliance of Patients’ Organizations (IAPO), International Conference on Rare Diseases & Orphan Drugs (ICORD), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), International Federation of Human Genetics Societies (IFHGS).
“RDI creates a united global patient voice for all people living with a rare disease around the world, including those who don’t have a voice today, and works to turn ignorance, isolation and exclusion into knowledge, solidarity and hope,” says Yann Le Cam, Chief Executive Officer of EURORDIS, the European Organisation for Rare Diseases.
For further information
News archives
Showing 10 posts of 953 posts found.
-
Title
Date
